Annual Accounts Payable
$10.95 M
+$2.63 M+31.56%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual accounts payable is $10.95 million, with the most recent change of +$2.63 million (+31.56%) on December 31, 2023.
- During the last 3 years, INBX annual accounts payable has fallen by -$2.50 million (-18.61%).
- INBX annual accounts payable is now -18.61% below its all-time high of $13.46 million, reached on December 31, 2020.
Performance
INBX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$12.37 M
-$651.00 K-5.00%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly accounts payable is $12.37 million, with the most recent change of -$651.00 thousand (-5.00%) on September 30, 2024.
- Over the past year, INBX quarterly accounts payable has dropped by -$651.00 thousand (-5.00%).
- INBX quarterly accounts payable is now -18.54% below its all-time high of $15.19 million, reached on September 30, 2020.
Performance
INBX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
INBX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.6% | -5.0% |
| 3 y3 years | -18.6% | +13.3% |
| 5 y5 years | +67.8% | +13.3% |
INBX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.6% | -5.0% | +57.4% |
| 5 y | 5-year | -18.6% | +251.7% | -18.5% | +297.1% |
| alltime | all time | -18.6% | +1313.4% | -18.5% | +349.3% |
Inhibrx Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.37 M(-5.0%) |
| Jun 2024 | - | $13.02 M(+5.3%) |
| Mar 2024 | - | $12.37 M(+48.8%) |
| Dec 2023 | $10.95 M(+31.6%) | $8.31 M(+5.8%) |
| Sep 2023 | - | $7.86 M(-19.0%) |
| Jun 2023 | - | $9.70 M(-11.1%) |
| Mar 2023 | - | $10.92 M(+31.1%) |
| Dec 2022 | $8.33 M(-8.8%) | $8.33 M(-2.8%) |
| Sep 2022 | - | $8.57 M(-7.3%) |
| Jun 2022 | - | $9.25 M(+17.2%) |
| Mar 2022 | - | $7.89 M(-13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $9.13 M(-32.2%) | $9.13 M(-26.6%) |
| Sep 2021 | - | $12.43 M(+26.0%) |
| Jun 2021 | - | $9.86 M(-31.0%) |
| Mar 2021 | - | $14.29 M(+6.2%) |
| Dec 2020 | $13.46 M(+332.0%) | $13.46 M(-11.4%) |
| Sep 2020 | - | $15.19 M(+70.5%) |
| Jun 2020 | - | $8.91 M(+186.0%) |
| Dec 2019 | $3.12 M(-52.3%) | $3.12 M(+13.1%) |
| Jun 2019 | - | $2.75 M(-24.7%) |
| Mar 2019 | - | $3.66 M |
| Dec 2018 | $6.53 M(+742.6%) | - |
| Dec 2017 | $775.00 K | - |
FAQ
- What is Inhibrx Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual accounts payable year-on-year change?
- What is Inhibrx Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly accounts payable year-on-year change?
What is Inhibrx Biosciences annual accounts payable?
The current annual accounts payable of INBX is $10.95 M
What is the all time high annual accounts payable for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual accounts payable is $13.46 M
What is Inhibrx Biosciences annual accounts payable year-on-year change?
Over the past year, INBX annual accounts payable has changed by +$2.63 M (+31.56%)
What is Inhibrx Biosciences quarterly accounts payable?
The current quarterly accounts payable of INBX is $12.37 M
What is the all time high quarterly accounts payable for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly accounts payable is $15.19 M
What is Inhibrx Biosciences quarterly accounts payable year-on-year change?
Over the past year, INBX quarterly accounts payable has changed by -$651.00 K (-5.00%)